Navigation Links
Northeastern's Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC

Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.

The Barnett Institute of Chemical and Biological Analysis, a part of Northeastern University's College of Science, has recognized this need, and has partnered in the formation of BioAnalytix, LLCa company specializing in the application of advanced biologic drug characterization methods and technologies to enable better, faster and more effective drug development and commercialization.

With a strong and experienced board from the analytical sciences and pharmaceutical industry, the Barnett Institute wanted to help create a company that could directly serve pharmaceutical partners in key areas of biologic development. "Beyond its well established research position in advanced analytics, the Barnett Institute has for several yearsbeen working with leading pharmaceutical companies to develop and apply analytical methods in their areas of biologic development, and we continued to see the increasing opportunity to meet this need as a commercially orientedbusiness," said Barry Karger, Director of the Barnett Institute, James L. Waters Chair in Analytical Chemistry.

"It is really a terrific opportunity to bring leading research and advanced analytic capabilities into a business that can directly help improve and accelerate drug development processes, and reduce costs in the healthcare space overall," said BioAnalytix CEO, Kirt Poss.

The affiliation between the Barnett Institute and BioAnalytix will also enable a mutually beneficial opportunity in joint participation in leading research and policy areas, as well as increased project work with partners in combined areas of advanced research and commercial application,providing even more unique and applied opportunities for Northeastern students. "The spin-off of BioAnalytix not only leads to socially beneficial commercial development that we are not suited to do inside a university, but also keeps our research in contact with the cutting edge of technology in the biologic sector," said Murray Gibson, Dean of Northeastern's College of Science.


Contact: Lori Lennon
Northeastern University College of Science

Related medicine news :

1. Penn Translational Medicine Institute to hold 7th Annual Symposium
2. Scripps Research Institute scientists show protein linked to hunger also implicated in alcoholism
3. Weizmann Institutes mathematical model may lead to safer chemotherapy
4. Cedars-Sinai Heart Institute awarded $1.3 million to study cardiac stem cells
5. Astex, CRT and the Institute of Cancer Research announce epigenetic drug discovery collaboration
6. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
7. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim lead insulation paper
8. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim™ lead insulation paper
9. Researchers awarded National Cancer Institute grants aimed at answering provocative questions
10. JDRF-Helmsley Charitable Trust to fund islet encapsulation research at Diabetes Research Institute
11. A vaccine for heart disease? La Jolla Institute discovery points up this possibility
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: